|
|
Volumn 10, Issue 1, 2006, Pages
|
|
Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
BLOOD CLOTTING FACTOR 7A;
BRAIN HEMORRHAGE;
BRAIN INFARCTION;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
DISABILITY;
DISEASE COURSE;
DRUG DOSE COMPARISON;
DRUG DOSE ESCALATION;
EARLY INTERVENTION;
FUNCTIONAL STATUS;
HEART INFARCTION;
HEMATOMA;
HUMAN;
INTENSIVE CARE UNIT;
MORTALITY;
PRIORITY JOURNAL;
RANKIN SCALE;
RISK REDUCTION;
SHORT SURVEY;
SINGLE DRUG DOSE;
THROMBOEMBOLISM;
TREATMENT RESPONSE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
CEREBRAL HEMORRHAGE;
FACTOR VIIA;
HEMATOMA;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 34447576775
PISSN: 13648535
EISSN: 1466609X
Source Type: Journal
DOI: 10.1186/cc3978 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (5)
|
